Pharmacological Treatment of Neonatal Opiate Withdrawal
Author Information
Author(s): Anthony Liu, Tracey Björkman, Caroline Stewart, Ralph Nanan
Primary Institution: Sydney Medical School-Nepean, The University of Sydney
Hypothesis
What are the effects of opiate exposure in utero on neonatal withdrawal and neurodevelopment?
Conclusion
Prolonged use of opiates for neonatal withdrawal should be approached with caution due to potential harmful effects on neurodevelopment.
Supporting Evidence
- Neonatal withdrawal has surged more than 30-fold over the past two decades.
- Pharmacological management is required in 45–80% of cases of neonatal withdrawal.
- Prolonged exposure to opiates can interfere with normal brain development.
Takeaway
Babies born to mothers who used opiates during pregnancy might have problems, and doctors need to be careful when treating them with opiates after birth.
Methodology
Review of existing literature and clinical studies on neonatal opiate withdrawal and treatment approaches.
Potential Biases
Studies often fail to control for social and maternal factors that could influence outcomes.
Limitations
Current clinical research is limited, often methodologically flawed, and does not adequately control for confounding variables.
Participant Demographics
Neonates exposed to opiates in utero and their mothers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website